Identifying high-risk medication: a systematic literature review Eva A. SaedderBirgitte BrockMarianne Lisby Review Article 27 March 2014 Pages: 637 - 645
Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective Gaetano ZaccaraFabio GiovannelliJosemir W. Sander Review Article 28 March 2014 Pages: 647 - 654
The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial Afshin GharekhaniMohammad-Reza KhatamiMohammad-Ali Mansournia Clinical Trial 20 March 2014 Pages: 655 - 665
Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease Seiji HokimotoTadasuke ChitoseHisao Ogawa Clinical Trial 26 April 2014 Pages: 667 - 673
Investigation of combined CYP3A4 inductive/inhibitory properties by studying statin interactions: a model study with the renin inhibitor ACT-178882 Jasper DingemanseLaurent B. NicolasLuc van Bortel Clinical Trial 15 April 2014 Pages: 675 - 684
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients Ingrid LundeSara BremerHege Christensen Pharmacogenetics Open access 22 March 2014 Pages: 685 - 693
Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients Buster MannheimerJohan HolmErik Eliasson Pharmacogenetics 20 March 2014 Pages: 695 - 699
Family history of cardiovascular disease and influence on statin therapy persistence Anna CitarellaHelle KielerMorten Andersen Pharmacoepidemiology and Prescription 08 March 2014 Pages: 701 - 707
Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine Leo RussoGary SchneiderSusan Rosen Pharmacoepidemiology and Prescription Open access 11 March 2014 Pages: 709 - 717
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study M. JoergerC. Schaer-ThuerT. Cerny Pharmacoepidemiology and Prescription 11 March 2014 Pages: 719 - 725
Application of the Pareto principle to identify and address drug-therapy safety issues Fabian MüllerHarald DormannRenke Maas Pharmacoepidemiology and Prescription 21 March 2014 Pages: 727 - 736
Potentially inappropriate prescribing in elderly outpatients in Croatia Branislava PopovićNives Radošević QuadrantiVera Vlahović-Palčevski Pharmacoepidemiology and Prescription 21 March 2014 Pages: 737 - 744
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier Carlos AlvesFrancisco Batel MarquesAna Filipa Macedo Pharmacoepidemiology and Prescription 03 April 2014 Pages: 745 - 756
Primary non-adherence in general practice: a Danish register study Anton PottegårdRene dePont ChristensenJesper Hallas Pharmacoepidemiology and Prescription 23 April 2014 Pages: 757 - 763